☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
sunshine lake pharma
Sunshine Lake Pharma Reports P-I Study Results of Liraglutide Biosimilar RD12014 for Type 2 Diabetes
December 10, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.